French National Authority for Health (HAS) published new set of decisions by CNEDiMTS about add-on and medical aid reimbursement in June

03

Jul 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS).

Three decisions were released for coronary stents:

  • ULTIMASTER, drug-eluting coronary stent (request for amendment, approved)
  • RESOLUTE ONYX, drug-eluting coronary stent (request for amendment, approved)
  • BIOSS LIM C, drug-eluting bifurcation coronary stent (application for registration, approved)

Two decisions were published for portable oxygen concentrators:

  • ZEN-O RS-00500, portable oxygen concentrator (application for registration, approved)
  • XPO2, portable oxygen concentrator (application for renewal of registration, approved)

Three other decisions:

  • UROLIFT, intra-prostatic implant (application for registration, approved)
  • AXIUM, non-rechargeable implantable system for spinal ganglion stimulation (application for registration, approved)
  • Insulin pumps  (request for amendment of technical specifications, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

13

Jan 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2022. Nine recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern the device used for neuromodulation, the device for the treatment of benign prostatic hyperplasia, orthopedic devices, as well as medical aids.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more

10

Jan 2023

On December 17, 2022, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the transitional coverage for the renal denervation catheter SYMPLICITY SPYRAL.

Read more